These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23518313)

  • 1. Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2013 Jul; 46(10-11):901-8. PubMed ID: 23518313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological analysis of chronic lymphocytic leukemia: integration of mRNA and microRNA expression profiles.
    Dong L; Bi KH; Huang N; Chen CY
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
    Nana-Sinkam SP; Croce CM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia.
    Gioia G; Mortarino M; Gelain ME; Albonico F; Ciusani E; Forno I; Marconato L; Martini V; Comazzi S
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):228-35. PubMed ID: 21663977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in chronic lymphocytic leukemia.
    Ward BP; Tsongalis GJ; Kaur P
    Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.
    Zhang T; Davidson-Moncada JK; Mukherjee P; Furman RR; Bhavsar E; Chen Z; Hakimpour P; Papavasiliou N; Tam W
    Blood Cancer J; 2017 Sep; 7(9):e606. PubMed ID: 28885613
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of miR-15/16 in CLL.
    Pekarsky Y; Croce CM
    Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
    Nicoloso MS; Kipps TJ; Croce CM; Calin GA
    Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of miRNAs in diagnosis and prognosis.
    Tsongalis GJ; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):839. PubMed ID: 23726293
    [No Abstract]   [Full Text] [Related]  

  • 13. miRNA Biology in Chronic Lymphocytic Leukemia.
    Bayraktar R; Fontana B; Calin GA; Nemeth K
    Semin Hematol; 2024 Jun; 61(3):181-193. PubMed ID: 38724414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression in chronic lymphocytic leukaemia.
    Lawrie CH; Ballabio E; Dyar OJ; Jones M; Ventura R; Chi J; Tramonti D; Gooding S; Boultwood J; Wainscoat JS; Hatton CS; Schuh A
    Br J Haematol; 2009 Nov; 147(3):398-402. PubMed ID: 19681887
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-analytical variables in miRNA analysis.
    Becker N; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):861-8. PubMed ID: 23466658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and hematopoietic differentiation.
    Fatica A; Rosa A; Fazi F; Ballarino M; Morlando M; De Angelis FG; Caffarelli E; Nervi C; Bozzoni I
    Cold Spring Harb Symp Quant Biol; 2006; 71():205-10. PubMed ID: 17381298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
    De Cecco L; Capaia M; Zupo S; Cutrona G; Matis S; Brizzolara A; Orengo AM; Croce M; Marchesi E; Ferrarini M; Canevari S; Ferrini S
    PLoS One; 2015; 10(8):e0134706. PubMed ID: 26305332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.